PrimeGen Biotech, a privately-held research firm, has opened a new 10,000 square-foot research facility located in Santa Ana, Calif. Founded by co-founder of AST Computers and former CEO of SRS Labs, Thomas C.K. Yuen plans to utilize PrimeGen's new research facility and his experience in marketing technologies to lead PrimeGen's team of research scientists in the discovery of new breakthroughs in stem cell science, and bringing advanced treatments of degenerative and aging related diseases to market.

The company's ongoing research has shown promising signs that stem cells derived from various tissues in the body may serve specialized medical purposes. PrimeGen's new facility was designed to give its research team the space and tools necessary to delve deeper into the characterization of stem cells and their respective therapeutic value, while complying with FDA's Current Good Manufacturing Practice (CGMP) regulations, readying for the translational phase of their stem cell therapeutic objectives.

The new facility features five main laboratories dedicated to:

• Tissue Processing
• Cell Culture Research and Development
• Molecular Biology
• Flow Cytometry
• Histology.

"Stem cell research has come a long way since we started PrimeGen 13 years ago, and so have the techniques and technology requirements associated with the science," said Tom Yuen, CEO of PrimeGen Biotech. "Our new facility was custom designed and built featuring advanced laboratories filled with the latest equipment; allowing our research team to continue pioneering new uses for stem cells as regenerative medicine."